Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …

Human papillomavirus (HPV) types 16 and 18 cause 70% of cervical cancer cases globally.
The nonavalent HPV vaccine (9vHPV) was licensed in 2014 and protects against the next …

Current status of human papillomavirus vaccination : Current Opinion in Oncology Current status
of human papillomavirus vaccination : Current Opinion in Oncology Log in or Register Subscribe …

Globally, human papillomavirus (HPV) infection is one of the most common sexually
transmitted infection. HPV is linked to at least five malignancies including vulvar, vaginal …

Worldwide, cervical cancer is the second most common cancer of women. Less-developed
countries bear the greatest burden in terms of morbidity and mortality, largely due to the lack …

Cervical cancer is a malignant neoplasm arising from cells that originate in the cervix uteri. It
is the second most prevalent cancer among women. It can have several causes; an infection …

Vaccines are available against human papillomavirus (HPV), the causal agent of cervical
and other cancers. Efficacy data from the HPV-16/18 AS04-adjuvanted vaccine clinical trial …

An investigational monovalent human papillomavirus (HPV) 16 virus-like particle vaccine
has been shown to prevent persistent infection and cervical disease related to HPV 16 and …

At least 15% of human malignant diseases are attributable to the consequences of
persistent viral or bacterial infection. Chronic infection with oncogenic human papillomavirus …

BACKGROUND: Human papillomaviruses (HPVs) play an obligatory role in cervical cancer
devel-opment. Thus, immunization of women using a prophylactic vaccine against the most …